Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
about
Chronic hepatitis C and liver fibrosis.Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients.Review article: the endocannabinoid system in liver disease, a potential therapeutic target.Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.
P2860
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
@en
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
@nl
type
label
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
@en
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
@nl
prefLabel
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
@en
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
@nl
P2093
P2860
P356
P1476
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
@en
P2093
Giada Sebastiani
Konstantinos Gkouvatsos
Mario Plebani
P2860
P356
10.1515/CCLM.2011.001
P577
2010-10-20T00:00:00Z